Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioLineRx Ltd

BLRX
Current price
0.24 USD -0.021 USD (-8.23%)
Last closed 0.25 USD
ISIN US09071M2052
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 20 977 558 USD
Yield for 12 month -85.88 %
1Y
3Y
5Y
10Y
15Y
BLRX
21.11.2021 - 28.11.2021

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. Address: Modi?in Technology Park, Hevel Modi'in, Israel, 7177871

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.57 USD

P/E ratio

Dividend Yield

Current Year

+4 800 000 USD

Last Year

Current Quarter

+4 943 000 USD

Last Quarter

+5 393 000 USD

Current Year

+1 108 000 USD

Last Year

-654 000 USD

Current Quarter

+4 121 000 USD

Last Quarter

+4 496 000 USD

Key Figures BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -33 080 000 USD
Operating Margin TTM -107.05 %
PE Ratio
Return On Assets TTM -35.23 %
PEG Ratio 0.2
Return On Equity TTM -171.94 %
Wall Street Target Price 4.57 USD
Revenue TTM 17 048 000 USD
Book Value 0.012 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.3 USD
Diluted Eps TTM -0.3 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -176.67 %

Dividend Analytics BLRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 15.07.2019
Dividend Date 15.07.2019

Stock Valuation BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.2473
Price Sales TTM 1.2305
Enterprise Value EBITDA -0.6709
Price Book MRQ 2.4695

Financials BLRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BLRX

For 52 weeks

0.23 USD 1.77 USD
50 Day MA 0.43 USD
Shares Short Prior Month 1 059 760
200 Day MA 0.68 USD
Short Ratio 2.39
Shares Short 1 097 398
Short Percent 1.33 %